Community Practice

Latest News


CME Content


Ophthalmologists have noted an increase in an eye infection, called Acanthamoeba keratitis, caused by a parasite, among contact lens wearers. The infection has been linked to a lens cleaner called Complete MoisturePlus Multi Purpose Solution.

RESTAT, a PBM, will now make its data available on RxHub's national patient health information network to provide access to patient prescription information nationwide.

CMS is now soliciting bids for the first round of the Medicare Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Competitive Bidding Program.

More than a week after the initial deadline for registering for a National Provider Identifier (NPI) number passed, CMS released a dissemination notice that reveals that a key NPI database will be available soon.

The Consumer Healthcare Products Association (CHPA) applauded recent actions taken by many major retailers to prevent children under age 18 from purchasing OTC cough medicines that contain dextromethorphan.

The FDA said it will wait to further evaluate data submitted by manufacturer GlaxoSmithKline regarding the safety of its diabetes drug rosiglitazone (Avandia).

Low molecular weight heparin, enoxaparin (Lovenox, Sanofi-Aventis), has a new indication, the treatment of patients with acute ST-segment elevation myocardial infarction (STEMI).

You'll be seeing a lot of the term downstream entity. That's the handle CMS proposes to use to signify pharmacies or pharmacists who contract with PBMs, dubbed first-tier entities, that, in turn, contract with Part D plan sponsors.

New immunosuppressive regimens that combine Certican and low-dose Neoral to preverse renal function following heart transplants and Viagra to lower pulmonary arterial heypertension are coming soon to hospitals.

RFID progress still slow; ezScriptWriter for legible Rxs; reducing drug diversion through ImageWare Forensic Medicine Technology; Know Your Number health-risk addessment tool; e-prescriptions grow

Updated studies show that the greater use of life-enhancing highly active antiretroviral therapy, the more reports proliferate of unusal side effects, including lipodystrophy, lactic acidosis, insulin resistance, and recently, male osteoporosis.